Whalen HR et al. |
High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime. |
2017 |
Transplantation |
pmid:26950724
|
Saliba F et al. |
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial. |
2017 |
Am. J. Transplant. |
pmid:28133906
|
de Fijter JW et al. |
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial. |
2017 |
Am. J. Transplant. |
pmid:28027625
|
Kabat-Koperska J et al. |
Birth defects in juvenile Wistar rats after exposure to immunosuppressive drugs during pregnancy. |
2017 |
Histol. Histopathol. |
pmid:27097725
|
Elens L and Haufroid V |
Genotype-based tacrolimus dosing guidelines: with or without CYP3A4*22? |
2017 |
Pharmacogenomics |
pmid:29095105
|
Al-Uzri A et al. |
Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation. |
2017 |
Pediatr Transplant |
pmid:28635157
|
Ma X et al. |
Inhibition effect of tacrolimus and platelet-derived growth factor-BB on restenosis after vascular intimal injury. |
2017 |
Biomed. Pharmacother. |
pmid:28633129
|
Zidan AS |
Taste-masked tacrolimus-phospholipid nanodispersions: dissolution enhancement, taste masking and reduced gastric complications. |
2017 |
Pharm Dev Technol |
pmid:26811031
|
Ueno P et al. |
Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus. |
2017 |
Transplantation |
pmid:27490418
|
Li Y et al. |
[Study on the Effect of Immunosuppressive Agent FK506 on Growth and Migration of Lung Cancer Cell]. |
2017 |
Zhongguo Fei Ai Za Zhi |
pmid:28738959
|
Gu K et al. |
Atypical pneumonia due to human bocavirus in an immunocompromised patient. |
2017 |
CMAJ |
pmid:28507089
|
Nakamura Y et al. |
Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation. |
2017 |
Intern. Med. |
pmid:28502936
|
Sanghavi K et al. |
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. |
2017 |
Pharmacogenomics J. |
pmid:26667830
|
Heemann U and Viklicky O |
Is trough level variability the new tool for identifying patients at risk for rejection after transplantation? |
2017 |
Nephrol. Dial. Transplant. |
pmid:28186537
|
Undre N and Dickinson J |
Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants. |
2017 |
BMJ Open |
pmid:28377389
|
Størset E et al. |
Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. |
2017 |
Br J Clin Pharmacol |
pmid:28374426
|
Ericzon BG et al. |
Pharmacokinetics of prolonged-release tacrolimus versus immediate-release tacrolimus in de novo liver transplantation: A randomized phase III substudy. |
2017 |
Clin Transplant |
pmid:28295581
|
Lawrance IC et al. |
Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis. |
2017 |
Clin. Gastroenterol. Hepatol. |
pmid:28286194
|
Morita M et al. |
The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report. |
2017 |
Odontology |
pmid:27368962
|
Smolders EJ et al. |
Decreased tacrolimus plasma concentrations during HCV therapy: a drug-drug interaction or is there an alternative explanation? |
2017 |
Int. J. Antimicrob. Agents |
pmid:28185946
|
Shimizu S et al. |
Reduction of FR900525 using an S-(2-aminoethyl) l-cysteine-resistant mutant. |
2017 |
J. Biosci. Bioeng. |
pmid:28185832
|
Sakurai K et al. |
Efficacy of combination therapy with tacrolimus and mizoribine for cyclophosphamide-resistant ANCA-associated glomerulonephritis. |
2017 |
Int J Rheum Dis |
pmid:28205382
|
Liu MZ et al. |
IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients. |
2017 |
Acta Pharmacol. Sin. |
pmid:28112181
|
Nishiya Y et al. |
A new efficient method of generating photoaffinity beads for drug target identification. |
2017 |
Bioorg. Med. Chem. Lett. |
pmid:28108248
|
Chung BH et al. |
Suppressive Effect of 1α,25-Dihydroxyvitamin D3 on Th17-Immune Responses in Kidney Transplant Recipients With Tacrolimus-Based Immunosuppression. |
2017 |
Transplantation |
pmid:28107277
|
Wungwattana M and Savic M |
Tacrolimus interaction with nafcillin resulting in significant decreases in tacrolimus concentrations: A case report. |
2017 |
Transpl Infect Dis |
pmid:28067989
|
Ak K et al. |
Tacrolimus-Eluting Suture Inhibits Neointimal Hyperplasia: An Experimental In Vivo Study in Rats. |
2017 |
Eur J Vasc Endovasc Surg |
pmid:28065442
|
MartÃn-Fernández M et al. |
Effects of Cyclosporine, Tacrolimus, and Rapamycin on Osteoblasts. |
2017 |
Transplant. Proc. |
pmid:29149986
|
Ivulich S et al. |
Clinical Challenges of Tacrolimus for Maintenance Immunosuppression Post-Lung Transplantation. |
2017 |
Transplant. Proc. |
pmid:29149976
|
Nakamura K et al. |
AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts. |
2017 |
Eur. J. Pharmacol. |
pmid:27993641
|
Khan SA et al. |
Improvement in baroreflex control of renal sympathetic nerve activity in obese Sprague Dawley rats following immunosuppression. |
2017 |
Acta Physiol (Oxf) |
pmid:28456134
|
Gelens MACJ et al. |
No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure. |
2017 |
J. Diabetes Complicat. |
pmid:28720321
|
Wan T et al. |
Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy. |
2017 |
Int J Pharm |
pmid:28629978
|
Tremblay S and Alloway RR |
Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations. |
2017 |
AAPS J |
pmid:28717926
|
Chen P et al. |
Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients. |
2017 |
J Clin Pharm Ther |
pmid:27885697
|
Zhang W et al. |
Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation. |
2017 |
Transplantation |
pmid:28885495
|
Burbulla LF et al. |
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease. |
2017 |
Science |
pmid:28882997
|
Khan S et al. |
Tacrolimus-loaded nanostructured lipid carriers for oral delivery-in vivo bioavailability enhancement. |
2016 |
Eur J Pharm Biopharm |
pmid:27793753
|
Rebora A |
Tacrolimus and oral lichen planus. Possible absorption after mucosal application? |
2016 |
J Eur Acad Dermatol Venereol |
pmid:26372839
|
Wang N et al. |
Paclitaxel and Tacrolimus Coencapsulated Polymeric Micelles That Enhance the Therapeutic Effect of Drug-Resistant Ovarian Cancer. |
2016 |
ACS Appl Mater Interfaces |
pmid:26809267
|
Gabriel D et al. |
Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis. |
2016 |
J Control Release |
pmid:27639683
|
Yoo EC et al. |
Developmental changes of MPA exposure in children. |
2016 |
Pediatr. Nephrol. |
pmid:26743220
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Tsuji T et al. |
Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice. |
2016 |
Allergol Int |
pmid:26666476
|
Ren H et al. |
Phosphatase inhibition increases AQP2 accumulation in the rat IMCD apical plasma membrane. |
2016 |
Am. J. Physiol. Renal Physiol. |
pmid:27488997
|
Tanriover B et al. |
Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate. |
2016 |
Clin J Am Soc Nephrol |
pmid:27364616
|
Tsuji H et al. |
Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients. |
2016 |
Intern. Med. |
pmid:27301503
|
Peng L et al. |
Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy. |
2016 |
J. Formos. Med. Assoc. |
pmid:26315481
|
Castagna L et al. |
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide. |
2016 |
Bone Marrow Transplant. |
pmid:26595078
|
Taylor KM and Sparrow MP |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040166
|